NCT00756418View on ClinicalTrials.gov

Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 1, 2003

Primary Completion Date

August 28, 2004

Study Completion Date

August 28, 2004

Conditions
Asthma
Interventions
DRUG

montelukast

montelukast 5 mg QD 4-weeks.

DRUG

Theophylline

Theophylline 100 to 200 mg BID 4-weeks.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00756418 - Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396) | Biotech Hunter | Biotech Hunter